Targeting RAS proteins may prevent relapse in acute myeloid Leukaemia
Relapses in a common form of leukaemia may be preventable following new research which has…
Browsing: acute myeloid leukaemia
Outcomes after stem cell transplant in elderly patients with acute myeloid leukaemia have improved since 2000
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the…
Scientists devise novel strategy to seek and destroy leukaemia stem cells
Scientists at City of Hope, one of the largest cancer research and treatment organisations in…
Stopping the awakening of sleeping AML stem cells to prevent disease relapse
The mystery of why myeloid leukaemias start to grow again after chemotherapy has killed the…
Proteins suggest a path to reduce drug resistance in AML
Doctors have nearly a dozen new targeted drugs to treat patients with acute myeloid leukaemia,…
Leukaemia: Artificial intelligence provides support in diagnostics
Decisions on treatment for patients with acute myeloid leukaemia (AML) – a highly aggressive form of…
Finding and targeting a tumour’s sweet spot to eradicate AML
A highly aggressive common form of leukaemia which is activated by mutations in signalling molecules…
ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments
The treatment landscape for acute myeloid leukaemia (AML) is evolving rapidly, as research discoveries at Sylvester…
ASH 2023: Patients with a common form of acute myeloid leukaemia report better quality of life when treatment includes new drug quizartinib
In a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller…
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
Non-Hispanic Black patients with acute myeloid leukaemia (AML) are living longer, now that new therapies are available,…